Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Ingenito, O. Fruchter, F. Herth, R. Eberhardt, A. Valipour, S. Asadi, R. Bonnet, I. Maeder, A. Kempa, F. Stanzel, M. Kramer (Woburn, United States Of America; Petach Tikva, Israel; Heidelberg, Bad Berka, Hemer, Germany; Vienna, Austria). Emphysematous lung sealant (ELS) therapy reduces CRP, an index of inflammation, in patients with severe emphysema (clinicaltrials.gov #NCT NCT00884962). Eur Respir J 2013; 42: Suppl. 57, 2295

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Clinical evaluation of a new inhibitor of neutrophilic inflammation, tetomilast (OPC-6535), in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 527s Year: 2006 Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Safety and efficacy of emphysematous lung sealant (ELS) therapy for advanced emphysema out to 2 years Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Calculation of Scond between 0 and 3 lung turn over (Scond*) in mild to moderate chronic lung disease Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016 Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Source: Eur Respir J 2010; 35: 540-548 Year: 2010